Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
All content for Trends from the Trenches is the property of Bio-IT World and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
Episode: 30 - Howard Jacob On Funding, Rare Diseases, and the Origins of ARCH
Trends from the Trenches
30 minutes
1 year ago
Episode: 30 - Howard Jacob On Funding, Rare Diseases, and the Origins of ARCH
In this episode of Trends from the Trenches, host Stan Gloss speaks with Howard Jacob, vice president of genomics research at AbbVie. They discuss Jacob’s beginnings at AbbVie, data siloing and “my data vs. our data” issues, and the role of funding in plan execution and leadership support. Jacob also delves into the origins of the AbbVie R&D Convergence Hub (ARCH—winner of a 2023 Bio-IT World Innovative Practices Award), how they secured a sizable investment for its development, leveragin...
Trends from the Trenches
Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
